uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Benzinga · 04/17 14:30
U.S. stocks were lower, with the Dow Jones index falling around 550 points on Thursday.
Shares of uniQure N.V. (NASDAQ:QURE) rose sharply during Thursday's session after the company was granted FDA granted Breakthrough Therapy designation for AMT-130 for the treatment of Huntington’s disease.
uniQure shares jumped 45.3% to $13.65 on Thursday.
Here are some other big stocks recording gains in today's session.
- Structure Therapeutics Inc. (NASDAQ:GPCR) gained 21.4% to $22.49.
- Hertz Global Holdings, Inc. (NASDAQ:HTZ) rose 20.3% to $6.99 after Pershing Square Capital Management disclosed a stake via a 13F. CNBC reported that Pershing Square’s stake is 19.8%, through shares & swaps.
- Eli Lilly and Company (NYSE:LLY) gained 15.3% to $847.08 after the company announced topline Phase 3 results from its ACHIEVE-1 trial, which showed orforglipron demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines.
- Capricor Therapeutics, Inc. (NASDAQ:CAPR) rose 13.8% to $10.97.
- ClearPoint Neuro, Inc. (NASDAQ:CLPT) gained 13% to $13.02.
- VersaBank (NASDAQ:VBNK) rose 12% to $10.91.
- Evotec SE (NASDAQ:EVO) jumped 10.7% to $3.6200 following FY24 financial results.
- Avis Budget Group, Inc. (NASDAQ:CAR) gained 10.1% to $80.00. The move came as investors responded to news that billionaire investor Bill Ackman’s Pershing Square Capital Management significantly increased its stake in Hertz Global Holdings Inc (NASDAQ:HTZ).
- Insteel Industries, Inc. (NYSE:IIIN) gained 9.1% to $29.15 following second-quarter results.
- Fidelity National Information Services, Inc. (NYSE:FIS) shares jumped 7% to $73.41. Fidelity National Information Services unveiled two strategic moves—acquiring Global Payments' Issuer Solutions unit and selling its remaining stake in Worldpay.
- Dollar Tree, Inc. (NASDAQ:DLTR) gained 4.4% to $76.40.
Now Read This:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.